ribociclib,Abemaciclib
novartis,eli lilly
[]
great summary by dr. nadia harbeck on current status of cdk 4/6i including the first three abstracts of the #asco23 locoregional abstract session 
Assistant Professor, Breast Surgical Oncology & Assoc. PD, BSO Fellowship @MDAndersonNews. Alum of @UChiPritzker, @uchicagosurgery & @WUSTL. Tweets are my own.